Unless ind icated otherwise, the term "VEGF-binding molecu le" includes anti-VEGF antibodies, anti-VEGF antibody fragments, "anti-VEGF antibody-l ike molecu les" and conjugates with any of these.Antibodies include, but are not limited to, monoclonal and chimerized monoclonal antibod ies. The term"antibody" encompasses complete immunoglobul ins, like monoclonal antibodies produced byrecombinant expression in host cells, as well as VEGF-binding antibody fragments or "antibody-likemolecules", including single-chain antibodies and linear antibodies, so-called "S Ps" ("Small ModularImmunopharmaceuticals"), as e.g. described in WO02/0569 10 . Anti-V EGF antibody-l ike molecu lesinclude immunoglobu lin single variable domains, as defined herein. Other examples for antibody-l ikemolecules are immunoglobul in super fami ly antibod ies (IgSF), or CDR-grafted molecu les.